Synapse

← Paul M. Ridker

Papers by Paul M. Ridker

Page 3 · newest first

  1. Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarctionEuropean Heart Journal - Cardiovascular Pharmacotherapy · 2023
  2. Candidate loci shared among periodontal disease, diabetes and bone densityFrontiers in Endocrinology · 2023
  3. Coronary Flow Reserve, Inflammation, and Myocardial StrainSHILAP Revista de lepidopterología · 2022
  4. Interactions Between Genetic Risk and Diet Influencing Risk of Incident Female Gout: Discovery and Replication Analysis of Four Prospective CohortsArthritis & Rheumatology · 2022
  5. Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte RatioJAMA Cardiology · 2022
  6. Reducing cardiovascular risk with immunomodulators: a randomised active comparator trial among patients with rheumatoid arthritisAnnals of the Rheumatic Diseases · 2022
  7. Earlier treatment in adults with high lifetime risk of cardiovascular diseases: What prevention trials are feasible and could change clinical practice? Report of a National Heart, Lung, and Blood Institute (NHLBI) WorkshopAmerican Journal of Preventive Cardiology · 2022
  8. Comparative Effects of Low-Dose Rosuvastatin, Placebo, and Dietary Supplements on Lipids and Inflammatory BiomarkersJournal of the American College of Cardiology · 2022
  9. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular RiskNew England Journal of Medicine · 2022
  10. Interplay of Atherogenic Particle Number and Particle Size and the Risk of Coronary Heart DiseaseClinical Chemistry · 2022
  11. Cross-Ancestry Investigation of Venous Thromboembolism Genomic PredictorsCirculation · 2022
  12. Stroke genetics informs drug discovery and risk prediction across ancestriesNature · 2022
  13. Interleukin-6 and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes: New Insights From CANVASDiabetes Care · 2022
  14. Effect of statin therapy on muscle symptoms: an individual participant data meta-analysis of large-scale, randomised, double-blind trialsThe Lancet · 2022
  15. Inflammation drives residual risk in chronic kidney disease: a CANTOS substudyEuropean Heart Journal · 2022
  16. Sugar-Sweetened Beverage Consumption and Plasma Lipoprotein Cholesterol, Apolipoprotein, and Lipoprotein Particle Size Concentrations in US AdultsJournal of Nutrition · 2022
  17. Effects of Randomized Treatment With Icosapent Ethyl and a Mineral Oil Comparator on Interleukin-1β, Interleukin-6, C-Reactive Protein, Oxidized Low-Density Lipoprotein Cholesterol, Homocysteine, Lipoprotein(a), and Lipoprotein-Associated Phospholipase A2: A REDUCE-IT Biomarker SubstudyCirculation · 2022
  18. Association of Physical Activity With Bioactive Lipids and Cardiovascular EventsCirculation Research · 2022
  19. ApoA-I Infusion Therapies Following Acute Coronary Syndrome: Past, Present, and FutureCurrent Atherosclerosis Reports · 2022
  20. TET2-Driven Clonal Hematopoiesis and Response to CanakinumabJAMA Cardiology · 2022
  21. Elucidating the relationship between migraine risk and brain structure using genetic dataBrain · 2022
  22. Genome-wide pharmacogenetics of anti-drug antibody response to bococizumab highlights key residues in HLA DRB1 and DQB1Scientific Reports · 2022
  23. Cross-Ancestry Investigation of Venous Thromboembolism Genomic Predictors2022
  24. Warfarin Dosing in Patients With CYP2C9*5 Variant AllelesClinical Pharmacology & Therapeutics · 2022
  25. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk allelesNature Genetics · 2022
  26. Dissecting the IL‐6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6RBritish Journal of Clinical Pharmacology · 2021
  27. Canakinumab's Effect Against Subsequent Gout Flares and High‐Sensitivity C‐Reactive Protein Levels: A Causal Mediation AnalysisArthritis Care & Research · 2021
  28. Genetic studies of leptin concentrations implicate leptin in the regulation of early adiposity2021
  29. Exome-Derived Adiponectin-Associated Variants Implicate Obesity and Lipid Biology2021
  30. Obesity Partially Mediates the Diabetogenic Effect of Lowering LDL CholesterolDiabetes Care · 2021
  31. Genetic overlap analysis of endometriosis and asthma identifies shared loci implicating sex hormones and thyroid signalling pathwaysHuman Reproduction · 2021
  32. Interleukin-1β suppression dampens inflammatory leucocyte production and uptake in atherosclerosisCardiovascular Research · 2021
  33. Effect of Antithrombotic Therapy on Clinical Outcomes in Outpatients With Clinically Stable Symptomatic COVID-19JAMA · 2021
  34. Phenotypic and Genotypic Associations Between Migraine and Lipoprotein SubfractionsNeurology · 2021
  35. Effect of Low-Dose Methotrexate on eGFR and Kidney Adverse Events: A Randomized Clinical TrialJournal of the American Society of Nephrology · 2021
  36. Sugar-Sweetened Beverage Consumption May Modify Associations Between Genetic Variants in the CHREBP (Carbohydrate Responsive Element Binding Protein) Locus and HDL-C (High-Density Lipoprotein Cholesterol) and Triglyceride ConcentrationsCirculation Genomic and Precision Medicine · 2021
  37. Association of Plasma Branched-Chain Amino Acid With Biomarkers of Inflammation and Lipid Metabolism in WomenCirculation Genomic and Precision Medicine · 2021
  38. From RESCUE to ZEUS: will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction?Cardiovascular Research · 2021
  39. Homocysteine Is Associated With Future Venous Thromboembolism in 2 Prospective Cohorts of WomenArteriosclerosis Thrombosis and Vascular Biology · 2021
  40. Interleukin-6 Signaling and Anti-Interleukin-6 Therapeutics in Cardiovascular DiseaseCirculation Research · 2021
  41. Association Between Achieved ω-3 Fatty Acid Levels and Major Adverse Cardiovascular Outcomes in Patients With High Cardiovascular RiskJAMA Cardiology · 2021
  42. Testing the Effects of Disease‐Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET TrialACR Open Rheumatology · 2021
  43. Association Between Hemostatic Profile and MigraineNeurology · 2021
  44. Rosuvastatin for the prevention of venous thromboembolism: a pooled analysis of the HOPE-3 and JUPITER randomized controlled trialsCardiovascular Research · 2021
  45. The neutrophil–lymphocyte ratio: considerations for clinical applicationEuropean Heart Journal · 2021
  46. Association of Genetic Variants With Migraine Subclassified by Clinical Symptoms in Adult FemalesFrontiers in Neurology · 2021
  47. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles2021
  48. Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in WomenJAMA Cardiology · 2021
  49. The neutrophil–lymphocyte ratio and incident atherosclerotic events: analyses from five contemporary randomized trialsEuropean Heart Journal · 2020
  50. Association of the Mediterranean Diet With Onset of Diabetes in the Women’s Health StudyJAMA Network Open · 2020